Exxon Mobil's stock bounces after Gerdes gets bullish, citing valuation and growth drivers in Permian Basin, Guyana
Shares of Exxon Mobil Corp. (XOM) bounced 0.9% in premarket trading Friday, after the oil giant was upgraded at Gerdes Energy Research, citing valuation after the stock's recent selloff. Exxon's stock has tumbled 14.8% since closing at a record $120.20 on Sept. 27 to close Thursday at a four-month low. The selloff came as crude oil futures (CL.1) plunged 22.2% over the same time, before bouncing 1.2% on Friday. Gerdes' analyst John Gerdes raised his rating to buy after being at neutral since Sept. 11, but kept his stock price target at $123, which implies 20% upside from Thursday's close. He said that upside, and growth drivers via Exxon's moves to scale in the Permian Basin through the acquisition of Pioneer Natural Resources Co. (PXD) and Guyana are reasons behind him turning back to bullish. Year to date, Exxon's stock has slipped 7.1% through Thursday while the S&P 500 has advanced 17.4%. Crude oil futures have shed 8.1% this year.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-17-23 0638ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom